Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
5.90 Down 0.10(1.67%) 3:59PM EDT
Prev Close:6.00
Open:5.99
Bid:5.67 x 100
Ask:5.99 x 5000
1y Target Est:13.40
Beta:1.21
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.87 - 6.05
52wk Range:2.05 - 8.25
Volume:718,645
Avg Vol (3m):2,351,210
Market Cap:610.09M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKDown 1.67%610.09M
IMMUDown 1.15%287.26M
LRUSF 0.00%61.44M
THLDDown 0.24%247.47M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback